Compound ID | 2617
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Alcaligenes faecalis, Escherichia coli, Proteus sp., Klebsiella pneumoniae, and Pseudomonas aeruginosa |
| Description: | Natural product from Streptomyces violaceoruber (methylenomycin A; also by Streptomyces coelicolor) but chemically modified to improve biological activity; analogues with narrow-spectrum activity reported |
| Institute where first reported: | Fermentation Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan |
| Year first mentioned: | 1974 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||||
|
|
||||||||||||
|
|
||||||||||||